Drug ID: | NPD3412 |
Drug Name: | |
Molecular Formula: | C19H20O3 |
Canonical SMILES: | C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C |
Standard InCHI: | InChI=1S/C19H20O3/c1-10-9-22-18-12-6-7-13-11(5-4-8-19(13,2)3)15(12)17(21)16(20)14(10)18/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m0/s1 |
Standard InCHIKey: | GVKKJJOMQCNPGB-JTQLQIEISA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB003870 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 296.14 |
ALogP | 0.0397 |
MLogP | 3.22 |
XLogP | 4.812 |
HDA | 3 |
HBD | 0 |
Rotatable Bonds | 3 |
TPSA | 43.37 |
RO5 Violation | 0 |